The upregulation of the PI3K/AKT pathway renders Ewing tumors resistant to therapy [47, 48], and SOX2, a target of EWSR1-FLI1, inhibits ES cell apoptosis by activating the PI3K/AKT pathway [49]. This evidence concerns the gene AKT1 and Ewing sarcoma.